Login to Your Account

Bone Therapeutics Launches Phase III Cell Therapy Trial

By Cormac Sheridan
Staff Writer

Wednesday, November 14, 2012
Without much fanfare, Bone Therapeutics SA has begun a pivotal double-blinded Phase III trial of a cell therapy for osteonecrosis, a debilitating bone disorder affecting young adults.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription